Diabetic dietary supplements market is set to gain significant growth due to the aging population and increasing prevalence of diabetes, according to the latest market study by RationalStat

The report titled "Diabetic Dietary Supplements Market" assesses the regional and global market based on type, diabetes type, dosage form, distribution channel, and country. A comprehensive report provides a detailed historical and future market size with trend analysis. The report studies and provide a robust overview of the market share analysis by leading players, production analysis, brand share analysis, competition overview, strategic imperatives, annual sales figures, growth avenues, production overview, financial analysis, and competition assessment for the target players.

Market Overview and Dynamics: Consumption of diabetic dietary supplements is to rise during the forecast period owing to the growing geriatric population across the globe

The global diabetic dietary supplements market is expected to grow at a CAGR of around 4.2% during the forecast period of 2022-2028. The increasing prevalence of diabetes coupled with the growing geriatric population across the globe are the key factors expected to drive the demand for diabetic dietary supplements. In addition, the global anti-aging market is estimated at US$ 415 billion in 2021, with dietary supplements growing at a CAGR of 6%.
The global diabetic dietary supplements market is set to observe moderate growth in the next six years. Increasing awareness of people about supplements, the growing prevalence of obesity and diabetes among children and adolescents, and growing R&D to develop innovative diabetic food supplements are anticipated to drive the demand for diabetic dietary supplements across the globe.

North America is anticipated to dominate the global diabetic dietary supplements market due to advancements in the pharmaceutical and nutraceutical sector. In Asia Pacific, factors such as a growing elderly population, an increasing number of people with diabetes, and rising healthcare expenditures are driving the demand for diabetic dietary supplements. In Europe, the market is driven by the growing popularity of nutrient-rich food and the rising awareness regarding health.
Segmental Analysis
• On the basis of diabetes type, the type-2 diabetes segment is expected to account for a major share due to increasing chronic conditions in the geriatric population.
• Based on the distribution channel, the offline segment is expected to grow considerably during the forecast period. Hospitals and Clinical pharmacies hold the majority of the share of the total offline sales of diabetic dietary supplements.
• On the basis of region, North America is dominating the global diabetic dietary supplements market due to advancements in the pharmaceutical and nutraceutical sector.

Competition Analysis

The global diabetic dietary supplements market is fragmented in nature with the presence of various players operating in the global market. Public and Private players are investing highly in R&D for the development of the global market.
Moreover, these players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Acquisitions and product launches are among the key strategies adopted by the leading players across the world. For instance,
• In December 2021, Danone India (Danone SA) launched Protinex Diabetes Care with an aim to address the nutritional requirements of Indians with diabetes.
• In November 2019, India-based Dr. Reddy's Laboratories Ltd. announced the launch of Celevida in India to help manage blood glucose levels among Indian patients.

Some of the prominent players in the market are Abbott Laboratories Inc., Aksuvital Natural Products Co., Arkopharma, Bionova, Caelus Health, CuraLife Global, Danone SA, Dr. Reddy's Laboratories Ltd., Glucose Health Inc., Hexagon Nutrition Pvt. Ltd., La Grande P Ltd. (La Nutraceuticals), Lysulin Inc., Nature's Sunshine Products Inc., Nestlé Health Science, and Nutricia among others.

The RationalStat has segmented the global Diabetes Dietary Supplements Market on the basis of type, diabetes type, dosage form, distribution channel, and region.
• By Type
o Vitamins
o Minerals
o Protein
o Others (Dietary Fibers etc.)
• By Diabetes Type
o Type 1 Diabetes
o Type 2 Diabetes
• By Dosage Form
o Tablets
o Powder
o Others (Solutions etc.)
• By Distribution Channel
o Offline
 Hospitals Pharmacies
 Retail Pharmacies
o Online
• By Region
o North America
 US
 Canada
o Latin America
 Brazil
 Mexico
 Rest of Latin America
o Western Europe
 Germany
 UK
 France
 Spain
 Italy
 Benelux
 Nordic
 Rest of Western Europe
o Eastern Europe
 Russia
 Poland
 Rest of Eastern Europe
o Asia Pacific
 China
 Japan
 India
 South Korea
 Australia
 ASEAN (Indonesia, Vietnam, Malaysia, etc.)
 Rest of Asia Pacific
o Middle East & Africa
 GCC
 South Africa
 Turkey
 Rest of the Middle East & Africa

For more information about this report visit https://store.rationalstat.com/store/global-diabetic-dietary-supplements-market-analysis-forecast/

RationalStat LLC
Kimberly Shaw, Content and Press Manager
sales@rationalstat.com
Phone: +1 302 803 5429

About RationalStat LLC

RationalStat is an end-to-end US-based market intelligence and consulting company that provides comprehensive market research reports along with customized strategy and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the clients' needs. Additional services offered by the company include consumer research, country reports, risk reports, procurement intelligence, data analytics, and analytical dashboards.

This release was published on openPR.